Stefania Pittaluga, M.D., Ph.D.

Stefania Pittaluga, M.D., Ph.D.
Senior Research Physician
Laboratory of Pathology

Team Member of:

Elaine S. Jaffe, M.D.

Dr. Pittaluga’s research interests are concerned with the molecular pathogenesis of lymphomas and the characterization of primary immunodeficiency disorders.

Areas of Expertise

1) hematopathology, 2) lymphomas, 3) primary immunodeficiency, 4) in-situ hybridization

Contact Info

Stefania Pittaluga, M.D., Ph.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room 2S235A
Bethesda, MD 20892-1500
Ph: 301-480-8465
Fax: 301-480-8089
stefpitt@mail.nih.gov
Permalink

Dr. Pittaluga’s research focuses on the molecular pathogenesis of lymphomas and the characterization of primary immunodeficiency disorders.

NIH Scientific Focus Areas:
Clinical Research

Selected Recent Publications

  1. Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort..
    Lau CY, Mihalek AD, Wang J, Dodd LE, Perkins K, Price S, Webster S, Pittaluga S, Folio LR, Rao VK, Olivier KN.
    Ann Am Thorac Soc. 13(8): 1279-88, 2016. [ Journal Article ]
  2. The genetic landscape of dural marginal zone lymphomas.
    Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G.
    Oncotarget. 7(28): 43052-43061, 2016. [ Journal Article ]
  3. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES.
    Hum Pathol. 55: 108-16, 2016. [ Journal Article ]
  4. Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.
    Laurent C, Fabiani B, Do C, Tchernonog E, Cartron G, Gravelle P, Amara N, Malot S, Palisoc MM, Copie-Bergman C, Glehen AT, Copin MC, Brousset P, Pittaluga S, Jaffe ES, Coppo P.
    Haematologica. 101(8): 976-84, 2016. [ Journal Article ]
  5. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
    Cohen JI, Dropulic L, Hsu AP, Zerbe CS, Krogmann T, Dowdell K, Hornung RL, Lovell J, Hardy N, Hickstein D, Cowen EW, Calvo KR, Pittaluga S, Holland SM.
    Clin Infect Dis. 63(1): 41-7, 2016. [ Journal Article ]

Dr. Pittaluga received her M.D. from the University of Sassari (Italy) and her Ph.D. in medical sciences from the Catholic University of Leuven (Belgium). She completed her clinical training in anatomic pathology at the Hebrew University Hadassah Medical School in Jerusalem (Israel) and at the National Cancer Institute (NCI) in Bethesda, Maryland. She also completed a fellowship in hematopathology at the NCI. She has been a staff clinician in the Hematopathology Section since 1999 and Program Director of the Hematopathology Fellowship program at the NIH/NCI since 2005. As Program Director, she is an active member of the Graduate Medical Education Committee (GMEC) and past Chair.

Dr. Pittaluga has been recognized for research excellence by the NCI, the National Heart Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID).  She is a past member of the Scientific Committee on Hematopathology and Clinical Laboratory Hematology for the American Society of Hematology.